Ceftriaxone Sodium
Sponsors
National Institute of Allergy and Infectious Diseases (NIAID), University of Southern California, Vion Pharmaceuticals, Merck Sharp & Dohme LLC, Pfizer
Conditions
Antibiotic ProphylaxisHIV InfectionsHIV-1-infectionInfectionIntra-abdominal InfectionsLiver DysfunctionMalnutrition, ChildNeurosyphilis
Phase 1
Phase 2
Phase 3
Efficacy and Safety of Ertapenem Sodium (MK-0826) Following Colorectal Surgery in Chinese Adults (MK-0826-056)
CompletedNCT01254344
Start: 2010-12-31End: 2011-12-31Updated: 2017-03-22
A Phase 3 Study Of Intravenous Metronidazole For Intrabdominal Infection
CompletedNCT01473836
Start: 2011-11-30End: 2012-10-31Updated: 2014-01-24
Prophylactic Antibiotic Use in Transarterial Chemoembolization for Hepatocellular Carcinoma
NCT05654896
Start: 2022-11-26End: 2023-12-26Target: 158Updated: 2022-12-16
Phase 4
Assessing Parenteral Antibiotics Versus Single-time Intra-operative Intra-dermal Antibiotic Administration for Prevention of SSI
WithdrawnNCT04975945
Start: 2021-08-31End: 2022-01-31Updated: 2025-03-25
Mecobalamin Combined With Ceftriaxone Sodium in the Treatment of Sepsis Liver Injury
Not yet recruitingNCT06220929
Start: 2024-01-15End: 2025-01-01Target: 40Updated: 2024-01-24
Unknown Phase
Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients
CompletedNCT00002052
Updated: 2005-06-24
A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive Individuals
CompletedNCT00000648
End: 1996-02-29Target: 100Updated: 2021-10-27